Search
Search Results
##search.searchResults.foundPlural##
-
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3361PDF: 1232HTML: 1717Untitled: 240Untitled: 245Untitled: 220 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2895PDF: 912HTML: 407Figure 1: 261 -
CHRONIC MYELOPROLIFERATIVE NEOPLASMS: A COLLABORATIVE APPROACH
1841PDF: 829HTML: 2367 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1494PDF: 927HTML: 161 -
SOLITARY PLASMACYTOMA
4455PDF: 2327HTML: 1456fIGURES 1,2: 295 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2126PDF: 1157HTML: 291 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
900PDF: 732HTML: 158 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1810PDF: 873HTML: 1348 -
PROPHYLAXIS OF MALARIA
3188PDF: 1144HTML: 18086Figures SChwartz: 227 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6601PDF: 2290HTML: 14187Untitled: 273figure: 245 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2687PDF: 893HTML: 1769 -
-
The MINI-POLATUZUMAB VEDOTINE PLUS CHP (POLA-R-CHP) VS. MINI-R-CHOP IN PATIENTS OVER 80 YEARS OF AGE WITH DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE, PROPENSITY SCORE-MATCHED ANALYSIS STRATIFIED BY SIMPLIFIED FRAILTY SCORE PolaRCHP vs. RCHOP for older patients
1629PDF: 598HTML: 366 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
4069PDF: 1013HTML: 488Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 268 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2958PDF: 1217HTML: 2709 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3347PDF: 984HTML: 7329Kost Fig1: 249Kost Fig 2: 231Kost Fig3: 252Kost Fig 4: 266Kost Fig5: 255Kost fig 6: 250 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
1125PDF: 603HTML: 354 -
Common variable immunodeficiency due to a novel NFKB1 variant in a child with thalassemia major CVID with thalassemia major
892PDF: 661HTML: 211 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
4332PDF: 1210HTML: 928 -
Skin Manifestations associated with Mantle cell Lymphoma: a case report
1734PDF: 895HTML: 2223Untitled: 291Untitled: 261Untitled: 249Untitled: 283Untitled: 275 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1351PDF: 601HTML: 1730Figures: 226Fifures Sanz: 234tables Sanz: 239Untitled: 230







